Oppenheimer analyst Noah Kaye maintains BorgWarner (NYSE:BWA) with a Outperform and raises the price target from $50 to $57.
RBC Capital Maintains Outperform on Kinaxis, Raises Price Target to C$200
RBC Capital analyst Paul Treiber maintains Kinaxis (TSX:KXS) with a Outperform and raises the price target from C$175 to C$200.
